Cardiovascular Disease

 

Increased Number of Menopause Symptoms Tied to Increased Cardiovascular Disease Risk

September 29, 2020

An analysis of data from the Women's Health Initiative is offering clinicians a look into the impact of menopause symptoms on cardiovascular health in older women.

David Cherney, MD: SGLT2 Inhibitors and Prescribing Responsibility

September 28, 2020

An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.

Pediatric Asthma Treatment Could Increase Risk of Diabetes, Other Conditions

September 18, 2020

New research suggests children treated with high-doses of oral glucocorticoids could be at a greater risk of diabetes, hypertension, and venous thromboembolism.

Adverse Pregnancy Outcomes Could Predict ASCVD Later in Life

September 17, 2020

Data from the WHI indicates adverse pregnancy outcomes were associated with increased risk of ASCVD later in life.

Matthew Budoff, MD: Clinical Usefulness of CAC Scores

September 11, 2020

An interview examining the use of coronary artery calcium scores for predicting CV events and stroke risk in real-world settings.

Cardiometabolic Health Fellowships: The Answer or Part of the Problem?

September 06, 2020

Melissa Young, MD, offers perspective on the push to create cardiometabolic fellowships versus making endocrinology a more desirable field.

CV Benefit of Dulaglutide Present Regardless of Background Metformin Use

September 05, 2020

An analysis from ESC Congress 2020 is shedding further light on the effects of dulaglutide in patients with and without background metformin use.

DAPA-CKD Details Effects of Dapagliflozin on CKD in Diabetics and Nondiabetics

September 04, 2020

Full results of DAPA-CKD further inform clinicians on dapagliflozin and use of SGLT2 inhibitors in those with and without diabetes.

Galectin-3 Plasma Levels Help Predict Cardiovascular Events in Diabetics

September 03, 2020

An ESC Congress 2020 study details the predictive value of galectin-3 levels for predicting risk of cardiovascular events in patients with type 2 diabetes

Joshua Denson, MD: Impact of Metabolic Syndrome in COVID-19 Patients

September 02, 2020

A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals.